THE NOVEL T-TYPE CA2-CHANNEL ANTAGONIST MIBEFRADIL EXERTS POTENT VASODILATORY EFFECTS WITHOUT REDUCING THE INTRACELLULAR SYSTOLIC CA2+-TRANSIENT AND FORCE OF CONTRACTION IN HUMAN MYOCARDIUM()
K. Brixius et al., THE NOVEL T-TYPE CA2-CHANNEL ANTAGONIST MIBEFRADIL EXERTS POTENT VASODILATORY EFFECTS WITHOUT REDUCING THE INTRACELLULAR SYSTOLIC CA2+-TRANSIENT AND FORCE OF CONTRACTION IN HUMAN MYOCARDIUM(), Circulation, 96(8), 1997, pp. 771-771